- Home
- PRME vs ATOM Comparison
PRME vs ATOM Comparison
Compare PRME & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- ATOM
- Stock Information
- Founded
- PRME 2019
- ATOM 2001
- Country
- PRME United States
- ATOM United States
- Employees
- PRME N/A
- ATOM N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- ATOM Semiconductors
- Sector
- PRME Health Care
- ATOM Technology
- Exchange
- PRME Nasdaq
- ATOM Nasdaq
- Market Cap
- PRME 191.7M
- ATOM 155.4M
- IPO Year
- PRME 2022
- ATOM 2016
- Fundamental
- Price
- PRME $3.57
- ATOM $3.39
- Analyst Decision
- PRME Buy
- ATOM
- Analyst Count
- PRME 6
- ATOM 0
- Target Price
- PRME $8.88
- ATOM N/A
- AVG Volume (30 Days)
- PRME 4.4M
- ATOM 466.1K
- Earning Date
- PRME 08-07-2025
- ATOM 08-05-2025
- Dividend Yield
- PRME N/A
- ATOM N/A
- EPS Growth
- PRME N/A
- ATOM N/A
- EPS
- PRME N/A
- ATOM N/A
- Revenue
- PRME $4,961,000.00
- ATOM $49,000.00
- Revenue This Year
- PRME $126.92
- ATOM $202.22
- Revenue Next Year
- PRME $87.32
- ATOM $1,225.00
- P/E Ratio
- PRME N/A
- ATOM N/A
- Revenue Growth
- PRME 739.42
- ATOM N/A
- 52 Week Low
- PRME $1.11
- ATOM $2.31
- 52 Week High
- PRME $5.17
- ATOM $17.55
- Technical
- Relative Strength Index (RSI)
- PRME 46.93
- ATOM 29.52
- Support Level
- PRME $3.35
- ATOM $3.49
- Resistance Level
- PRME $3.88
- ATOM $3.80
- Average True Range (ATR)
- PRME 0.38
- ATOM 0.29
- MACD
- PRME -0.12
- ATOM -0.11
- Stochastic Oscillator
- PRME 16.00
- ATOM 6.36
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.